Asia-Pacific Journal of Ophthalmology
&
Volume 2, Number 3, May/June 2013
4. Liu DT, Fok AT, Lam DSC. An update on the diagnosis and management of central serous chorioretinopathy. Asia-Pac J Ophthalmol. 2012;1:296Y302.
Reply to Letter to the Editor Regarding Central Serous Chorioretinopathy Dear Editor:
W
e would like to say thank you to Dr Lee for the inspiring suggestions.
Central serous chorioretinopathy (CSC) will very rarely present with subretinal fibrosis. Subretinal surgery such as dissection and extraction of fibrin scar is understandingly carrying significant surgical risks such as permanent damage to photoreceptors, retinal pigment epitheliums, and choroid. Differentiation between multifocal CSC and Vogt Koyanagi Harada should not be particularly difficult after careful clinical examination and a simple fundal fluorescein angiography. Multifocal CSC is not the usual manifestation of CSC. Multifocality in CSC may invariably denote a substantial underlying cause such
Letters to the Editor
as exogenous corticosteroids. Primary management of multifocal CSC usually involves diminution or even revoking of the exogenous corticosteroids. If this is futile, one may consider treatment such as safetyenhanced photodynamic therapy which could be systemically delivered to the lesion areas in the manner of a sequential photodynamic therapy. David Liu Department of Ophthalmology and Visual Sciences The Chinese University of Hong Kong Hong Kong, People’s Republic of China
‘‘Gratitude makes sense of our past, brings peace for today, and creates a vision for tomorrow.’’ - Melody Beattie
* 2013 Asia Pacific Academy of Ophthalmology
Copyright © 2013 Asia Pacific Academy of Ophthalmology. Unauthorized reproduction of this article is prohibited.
207
&
Volume 2, Number 3, May/June 2013
4. Liu DT, Fok AT, Lam DSC. An update on the diagnosis and management of central serous chorioretinopathy. Asia-Pac J Ophthalmol. 2012;1:296Y302.
Reply to Letter to the Editor Regarding Central Serous Chorioretinopathy Dear Editor:
W
e would like to say thank you to Dr Lee for the inspiring suggestions.
Central serous chorioretinopathy (CSC) will very rarely present with subretinal fibrosis. Subretinal surgery such as dissection and extraction of fibrin scar is understandingly carrying significant surgical risks such as permanent damage to photoreceptors, retinal pigment epitheliums, and choroid. Differentiation between multifocal CSC and Vogt Koyanagi Harada should not be particularly difficult after careful clinical examination and a simple fundal fluorescein angiography. Multifocal CSC is not the usual manifestation of CSC. Multifocality in CSC may invariably denote a substantial underlying cause such
Letters to the Editor
as exogenous corticosteroids. Primary management of multifocal CSC usually involves diminution or even revoking of the exogenous corticosteroids. If this is futile, one may consider treatment such as safetyenhanced photodynamic therapy which could be systemically delivered to the lesion areas in the manner of a sequential photodynamic therapy. David Liu Department of Ophthalmology and Visual Sciences The Chinese University of Hong Kong Hong Kong, People’s Republic of China
‘‘Gratitude makes sense of our past, brings peace for today, and creates a vision for tomorrow.’’ - Melody Beattie
* 2013 Asia Pacific Academy of Ophthalmology
Copyright © 2013 Asia Pacific Academy of Ophthalmology. Unauthorized reproduction of this article is prohibited.
207
